The Discounted Cash Flow (DCF) valuation of China Grand Pharmaceutical and Healthcare Holdings Ltd (512.HK) is 9.08 HKD. With the latest stock price at 9.27 HKD, the upside of China Grand Pharmaceutical and Healthcare Holdings Ltd based on DCF is -2.0%.
Based on the latest price of 9.27 HKD and our DCF valuation, China Grand Pharmaceutical and Healthcare Holdings Ltd (512.HK) is a sell. selling 512.HK stocks now will result in a potential gain of 2.0%.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 8.3% | 7.1% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 6.38 - 15.77 | 9.08 |
| Upside | -31.2% - 70.1% | -2.0% |